Comparative analysis of lung cancer presentation between 1990 and 2003 Source: Eur Respir J 2005; 26: Suppl. 49, 321s Year: 2005
Time to diagnosis and time to therapy in patients with malignant pleural mesothelioma (MPM) compared to patients with lung cancer in Denmark 2007 to 2011. A quality assurance analysis Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012
Survival trend of patients with lung cancer (LC) in Cáceres (Spain) (1991-2003). Analysis based on TNM staging, histology, modality-treatment and time-period of diagnosis Source: Eur Respir J 2007; 30: Suppl. 51, 669s Year: 2007
Clinical features of bronchial carcinoid tumor – 10 years‘ experience (1996-2006) Source: Eur Respir J 2007; 30: Suppl. 51, 425s Year: 2007
Cardiologic findings in patients with bronchial carcinoid tumor – 10 years‘ experience (1996-2006) Source: Eur Respir J 2007; 30: Suppl. 51, 562s Year: 2007
Sleeve-pneumonectomy for lung cancer – survival and complications (update 2005) Source: Eur Respir J 2005; 26: Suppl. 49, 492s Year: 2005
Lung cancer in Berlin – NET of the lung; analysis of subgroups and impact on survival (2000 – 2008) Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013
Study of patients with lung cancer treated surgically in Albania during the period 2000-2003 Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009
Stage, therapy and surviving of small cell lung cancer: analysis of a nonselected patient collective 1993-1997 Source: Eur Respir J 2001; 18: Suppl. 33, 394s Year: 2001
Time trends in surgery for lung cancer in France from 2005 to 2012: a nationwide study Source: Eur Respir J 2015; 46: 1131-1139 Year: 2015
Validation of the TNM classification (6th ed. / 2003) in the staging of small-cell lung cancer (SCLC) Source: Eur Respir J 2003; 22: Suppl. 45, 163s Year: 2003
Survival at low lung function in cystic fibrosis: Cohort study from 1995 to 2010 Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis Year: 2012
The importance of pulmonary mineralogic analysis (PMA) in interstitial lung disease (ILD). A retrospective study of 226 samples from 2005 to 2011 Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis Year: 2013
Comparison of non-small cell lung cancer (NSCLC) management and survival in 1995 and 2005 at a London teaching hospital Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008
Changes in the patterns of care for lung cancer from 1996 to 2001 in an Australian region Source: Eur Respir J 2006; 28: Suppl. 50, 832s Year: 2006
Trends in adenocarcinoma in patients newly diagnosed with lung cancer in São Paulo from 1985 to 2005 Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology Year: 2007
Evolution of histological types of bronchopulmonary neoplasm between 1999-2005 in Iasi area Source: Eur Respir J 2006; 28: Suppl. 50, 89s Year: 2006
Analysis of epidemiological differences and occupations risk of lung cancer cases between 1995-2008 years in Turkey Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer Year: 2009
Results of lung decortication in chronic empyema (2000-2003) Source: Eur Respir J 2004; 24: Suppl. 48, 630s Year: 2004
Spectrum of interstitial lung disease in China from 2000 to 2012 Source: Eur Respir J, 52 (3) 1701554; 10.1183/13993003.01554-2017 Year: 2018